The evolution of ventricular assist devices and future perspectives
10.3969/j.issn.1004-8812.2025.03.008
- VernacularTitle:心室辅助装置的发展历程与未来展望
- Author:
Sheng-hua LI
1
;
Mei LIU
;
Han-luo LI
;
Ya-lan LEI
;
Xiao-ke SHANG
Author Information
1. 湖北工业大学生命科学与健康工程学院 中德生物医学中心-心脏动力与辅助技术实验室,湖北武汉 430068
- Publication Type:Journal Article
- Keywords:
Ventricular assist device;
Heart failure;
Artificial heart;
HeartMate Ⅲ;
EVAHEART 2;
Heart Con
- From:
Chinese Journal of Interventional Cardiology
2025;33(3):170-175
- CountryChina
- Language:Chinese
-
Abstract:
Ventricular assist devices(VADs)have emerged as a pivotal therapeutic option for end-stage heart failure,undergoing significant technological advancements from pneumatic membrane pumps to continuous-flow centrifugal pumps.This review provides a detailed overview of several VAD models,including HeartMate Ⅲ,EVAHEART 2,and Heart Con.The initial generation of VADs established a foundation for subsequent developments,despite the occurrence of frequent complications.The second generation of VADs demonstrated a notable improvement in patient prognosis but carried the risk of ventricular collapse.The third generation of VADs represents a further reduction in size,incorporating magnetic levitation technology to enhance durability and blood compatibility.In the future,the development of VADs will focus on better emulating the physiological function of the native heart,improving pulsatility,and extending device longevity.As technology advances,VADs are expected to offer heart failure patients with a greater range of treatment options and a higher quality of life.
